4/A

PRIMARY DOCUMENT

Company: INTEGRATED BIOPHARMA INC
Filed: December 19, 2018
Period of Report: December 19, 2018
Accession Number: 0001064900-18-000002

View Document ↗ View on SEC.gov ↗